Radius Health (RDUS) Tops Q4 EPS by 19c, Revenues Beat

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.23), $0.19 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $62.78 million versus the consensus estimate of $59.44 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance